Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The triglyceride metabolic pathway encompasses the biochemical events concerned with the synthesis, storage, breakdown, and transport of triglycerides—molecules composed of glycerol and three fatty acids that are the primary form of stored energy in animals. Synthesis (lipogenesis) occurs mainly in the liver and adipose tissue, with enzymes such as GPAT, AGPAT, and DGAT playing key roles. Triglycerides are stored in adipocytes and can be released as free fatty acids during lipolysis, which supports energy needs during fasting or increased physical activity. Transport through the blood occurs via chylomicrons and VLDL, with processing by lipases in tissues. Dysregulation of this pathway is central to the pathogenesis of metabolic syndrome, diabetes, cardiovascular disease, and other lipid disorders.
Activation or inhibition of enzymes in triglyceride synthesis/breakdown (e.g., inhibition of lipolysis, activation of lipoprotein lipase) Modulation of lipoprotein production and clearance Inhibition of intestinal absorption or hepatic secretion of triglycerides (e.g., MTTP inhibition)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triglyceride metabolic pathway.